A Phase II, Randomized, Double-Blind, Placebo-controlled, 24-week Dose Finding Study to evaluate the Efficacy and Safety of
20 mg
Investigator: Brannagan, Thomas H
Phone Number: 212-888-8516
A doubled-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Dextromethorphan and Quinidine...Diabetic
Neuropathy
Investigator: Brannagan, Thomas H
Phone Number: 212-888-8516
Long-Term Safety & Efficacy Study of Open-Label Treatment with 80 mg of MCC-257 in Patients with Mild to Moderate Diabetic
Polyneuropathy
Investigator: Brannagan, Thomas H
Phone Number: 212-888-8516
A Double-Blind, Placebo-Controlled, Parallel-Group Study of Rufinamide Given as Adjunctive Therapy in Patients with Refractory
Partial Seizures
Investigator: Harden, Cynthia L
Phone Number: x6-2346
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability
of RWJ-333369 ...
Investigator: Harden, Cynthia L
Phone Number: x6-2346
An Open-Label, Multicenter, Follow-Up Trial to Evaluate the Long-Term Safety and Efficacy of Brivaracetam as Adjunctive Treatment
at a Flexible Dose
Investigator: Harden, Cynthia L
Phone Number: x6-2346
An Open-label Extension Trial to Determine Safety and Efficacy of Long-term Oral SPM 927 in Patients with Partial Seizures
Investigator: Harden, Cynthia L
Phone Number: x6-2346
NEAD - Neurodevelopment Effects of Antiepileptic Drugs
Investigator: Harden, Cynthia L
Phone Number: x6-2346
NEAD-Neurodevelopment Effects of Antiepileptic Drugs
Investigator: Harden, Cynthia L
Phone Number: x6-2346
Progesterone Therapy versus Placebo for Women with Epilepsy
Investigator: Harden, Cynthia L
Phone Number: x6-2346
Randomized Evaluation of Long term anticoagulant therapy (RE-LY) comparing the efficacy and safety of two blinded doses dabigatran
. . .
Investigator: Jamieson, Dara G
Phone Number: 746-6575
Automated Response to Spontaneous Epileptiform Activity Using the External Responsive Neurostimulator System (eRNS)
Investigator: Kobylarz, Erik J
Phone Number: x6-2014
Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy
Investigator: Labar, Douglas R
Phone Number: x6-2337
Prospective Seizure Frequency Clinical Investigation (Protocol #1103-051)
Investigator: Labar, Douglas R
Phone Number: x6-2337
Responsive Neurostimulator (RNS) System Long-Term Treatment Clinical Investigation
Investigator: Labar, Douglas R
Phone Number: x6-2337
Responsive Neurostimulator System Feasibility Clinical Investigation
Investigator: Labar, Douglas R
Phone Number: x6-2337
Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy (SANTE) Protocol 1604
Investigator: Labar, Douglas R
Phone Number: x6-2337
SPOTRIAS: Neuroprotection with Statin Therapy for Acute Recovery Trial
Investigator: Leifer, Dana
Phone Number: 746-6575
Study of Acute Viprinex for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex) in
Subjects Beginning ...
Investigator: Leifer, Dana
Phone Number: 746-6575
Randomized, Double-Blind, Active (Pramipexole 0.5mg tid) & Placebo Controlled, Efficacy Study of Pramipexole, Given 0.5mg
& 0.75mg Bid Over a 12-week.
Investigator: Nirenberg, Melissa J.
Phone Number: 746-6575
A Placebo-Controlled, Randomized, Rater-Blinded Phase II Clinical Study of Gammagard Intravenous Innumoglobulin (IVIg)...
Investigator: Relkin, Norman R
Phone Number: x6-6581
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-center Trial of Pregabalin versus Placebo in the Treatment
of Neuropathic...
Investigator: Rubin, Michael
Phone Number: x6-2320
An Open-Label, Extension Safety and Efficacy Trial of Pregabalin in Subjects with Neuropathic Pain Associated with HIV Neuropathy
...
Investigator: Rubin, Michael
Phone Number: x6-2320
Central Processing of Visual Information
Investigator: Victor, Jonathan D
Phone Number: x6-2276
